Efficacy and Prognostic Factors of Docetaxel Combined with ADT on Metastatic Hormone-sensitive Prostate Cancer Patients

Efficacy and Prognostic Factors of Docetaxel Combined with ADT on Metastatic Hormone-sensitive Prostate Cancer Patients

Objective To assess the efficacy of docetaxel plus ADT on mHSPC patients and analyze the prognostic factors. Methods We retrospectively reviewed the clinical data of 107 mHSPC patients treated with docetaxel plus ADT. Co-primary end points were PSA PFS and rPFS. Univariable and multivariable Cox ana...

Full description

Bibliographic Details
Main Authors: LIU Sanhe, CUI Diansheng, JIA Quan'an, Duan Liqun, DENG Kangli, HUANG Lei, WEI Shaozhong
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2019-06-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
docetaxel
adt
metastatic hormone-sensitive prostate cancer
efficacy
prognostic factor
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2019.19.0051.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2019.19.0051.htm

Similar Items